BPC-157
Research peptide | Preclinical • Repair • Evidence gap
Common names: BPC 157 · body protection compound 157 · BPC-157 peptide
- Evidence searched through
- August 24, 2026
- Last reviewed
- August 24, 2026
- Current version
- 1.0
4V Take
What the research shows.
BPC-157 gets a lot of attention because animal and lab studies report effects in healing and repair models. The catch is that the human research is still extremely small. Right now we do not have enough good human evidence to establish how well it works, a validated dose or route, or its long-term safety.
Explore the evidenceResearch Interest
Why are people interested?
Researchers are studying BPC-157 across the approved public questions in this record. Those questions are areas of research interest, not guaranteed outcomes.
Evidence Context
What have researchers looked at?
This approved record brings together the research settings represented in its selected public sources. Evidence settings answer different questions, so human, animal, laboratory, and research-review findings stay distinct.
Current research context
Research stage describes the maturity of the current topic record. Source context describes the evidence settings represented in the selected public sources below; they are not interchangeable.
- Research stage
- Exploratory / Very Early Clinical
- Selected source context
- Human · Mixed · Research Review
At a Glance
Research snapshot.
- 01Human Research
Extremely limited, uncontrolled - 02Research Stage
Exploratory / Very Early Clinical - 03Research Breadth
Large preclinical literature - 04Human Safety
Critically limited
Research Pathway
Follow the questions.
Choose a pathway to read its approved 4V Take. Each view stays focused on one question at a time.
4V Take
Most BPC-157 efficacy evidence remains preclinical.
- Evidence bucket
- mixed
- Research stage
- exploratory human
- Route / format
- Not applicable
Explore the evidence
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
human synthesis
Mateescu DM et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.
human synthesis
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
4V Take
Human musculoskeletal evidence is limited to small uncontrolled reports.
- Evidence bucket
- human observational
- Research stage
- exploratory human
- Route / format
- Not applicable
Explore the evidence
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
human synthesis
Mateescu DM et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.
human synthesis
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
4V Take
A two-person IV pilot reported no measured adverse effects over a very short observation window, but cannot establish general safety.
- Evidence bucket
- human clinical
- Research stage
- exploratory human
- Route / format
- Not applicable
Explore the evidence
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
human synthesis
Mateescu DM et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.
human synthesis
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
4V Take
Published reviews through 2026 identify fewer than roughly 30 human participants across a handful of uncontrolled pilot studies, with no completed Phase II clinical trial.
- Evidence bucket
- mixed
- Research stage
- exploratory human
- Route / format
- Not applicable
Explore the evidence
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
human synthesis
Mateescu DM et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.
human synthesis
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
4V Take
Route, formulation, pharmacokinetics, product quality, and dosing remain poorly standardized.
- Evidence bucket
- mixed
- Research stage
- exploratory human
- Route / format
- Not applicable
Explore the evidence
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
human synthesis
Mateescu DM et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.
human synthesis
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
4V Take
The July 2026 PCAC recommendation is a compounding-policy recommendation, not evidence of FDA approval, proven efficacy, or established general safety.
- Evidence bucket
- mixed
- Research stage
- exploratory human
- Route / format
- Not applicable
Explore the evidence
regulatory/contextual
FDA July 23–24, 2026 PCAC meeting materials.
regulatory/contextual
WADA 2026 Prohibited List.
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
Selected Sources
Explore the evidence.
Open an approved public source to inspect its study context, limitations, and original record where available.
human direct
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. 2025.
2025 · PMID: 40131143 · peer reviewed
human synthesis
Mateescu DM et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.
2026 · PMID: 42198317 · peer reviewed
human synthesis
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
2026 · PMID: 40756949 · peer reviewed
human synthesis
Regeneration or Risk? Narrative review of BPC-157 for musculoskeletal healing.
2026 · PMID: 40789979 · peer reviewed
human synthesis
Injectable Peptide Therapy primer/review.
2026 · PMID: 41476424 · peer reviewed
regulatory/contextual
FDA July 23–24, 2026 PCAC meeting materials.
2026 · URL: https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026 · contextual
regulatory/contextual
WADA 2026 Prohibited List.
2026 · URL: https://www.wada-ama.org/en/resources/world-anti-doping-program/prohibited-list · contextual
Research Status
Living research, deliberately tracked.
- Evidence searched globally through:
- August 24, 2026
- Last reviewed
- August 24, 2026
- Version
- 1.0
What Changed
Current record.
No later approved public release is available beyond the current topic record.
Evidence Boundaries
What are researchers still working out?
Study settings, measures, and limitations matter. A mechanism does not establish an outcome, animal or laboratory findings do not establish a human benefit, and a small study does not create consensus. Open each selected source for the approved record behind its finding.
Regulatory Context
Context, not a shortcut.
This topic’s selected public record includes regulatory or other context sources. They can help explain the setting in which research is discussed, but regulatory status does not by itself prove or disprove scientific value. Open the original source for its exact context.
Save / Follow
Keep this research close.
Save and Follow remain private account preferences. Following does not activate monitoring or notifications.
Loading member research actions.